Mechanisms of action of mycophenolate mofetil in preventing chronic rejection
- PMID: 12431636
- DOI: 10.1016/s0041-1345(02)03538-8
Mechanisms of action of mycophenolate mofetil in preventing chronic rejection
Similar articles
-
Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation.Transplant Proc. 1994 Dec;26(6):3205-10. Transplant Proc. 1994. PMID: 7998117 Review. No abstract available.
-
Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.Transplant Proc. 2002 Sep;34(6):2089-90. doi: 10.1016/s0041-1345(02)02863-4. Transplant Proc. 2002. PMID: 12270325 Clinical Trial. No abstract available.
-
Inhibition of early chronic rejection in rat aortic allografts by mycophenolate mofetil (RS61443).Transplant Proc. 1995 Feb;27(1):435. Transplant Proc. 1995. PMID: 7879051 No abstract available.
-
Mycophenolate mofetil in the prevention of rejection after kidney transplantation.Transplantation. 2000 Apr 27;69(8):1753-4. doi: 10.1097/00007890-200004270-00045. Transplantation. 2000. PMID: 10836400 No abstract available.
-
Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.Drug Saf. 1997 Aug;17(2):75-92. doi: 10.2165/00002018-199717020-00001. Drug Saf. 1997. PMID: 9285199 Review.
Cited by
-
Current concepts regarding Graves' orbitopathy.J Intern Med. 2022 Nov;292(5):692-716. doi: 10.1111/joim.13524. Epub 2022 Jun 1. J Intern Med. 2022. PMID: 35604323 Free PMC article. Review.
-
Management of Graves Thyroidal and Extrathyroidal Disease: An Update.J Clin Endocrinol Metab. 2020 Dec 1;105(12):3704-20. doi: 10.1210/clinem/dgaa646. J Clin Endocrinol Metab. 2020. PMID: 32929476 Free PMC article. Review.
-
Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease.J Clin Endocrinol Metab. 2022 Aug 8;107(Suppl_1):S13-S26. doi: 10.1210/clinem/dgac328. J Clin Endocrinol Metab. 2022. PMID: 36346686 Free PMC article.
-
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.Nat Rev Endocrinol. 2020 Feb;16(2):104-116. doi: 10.1038/s41574-019-0305-4. Epub 2019 Dec 30. Nat Rev Endocrinol. 2020. PMID: 31889140 Review.
-
Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy.J Endocrinol Invest. 2016 Jun;39(6):687-94. doi: 10.1007/s40618-016-0441-9. Epub 2016 Feb 17. J Endocrinol Invest. 2016. PMID: 26886940
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources